Skip to main content
logo
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.330
+0.030 (1.30%)
At close: May 6, 2026, 4:00 PM EDT
2.370
+0.040 (1.72%)
After-hours: May 6, 2026, 7:52 PM EDT

Neumora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4263121,7142,708--
Market Cap Growth
298.73%-81.80%-36.70%---
Enterprise Value
298.14184.121,4072,25600
Last Close Price
2.331.7910.6017.05--
PE Ratio
--1.23-6.93-4.70--
PB Ratio
3.913.005.975.77--
P/TBV Ratio
3.672.825.892.36--
P/FCF Ratio
--1.51-9.37-16.57--
P/OCF Ratio
--1.51-9.37-16.59--
EV/EBITDA Ratio
--0.76-5.35-8.97--
EV/EBIT Ratio
--0.76-5.34-8.95--
EV/FCF Ratio
--0.89-7.69-13.81--
Debt / Equity Ratio
0.530.5300.00-0.010.00
Debt / EBITDA Ratio
-0.23-0.23-0.01-0.02-0.06-0.01
Debt / FCF Ratio
-0.27-0.27-0.01-0.03-0.07-0.03
Net Debt / Equity Ratio
-1.23-1.23-1.06-0.960.811.25
Net Debt / EBITDA Ratio
0.530.531.161.792.691.72
Net Debt / FCF Ratio
0.620.621.672.753.155.34
Quick Ratio
5.625.6210.2918.0815.6917.58
Current Ratio
5.875.8710.5119.0516.3717.85
Return on Equity (ROE)
-121.21%-121.21%-64.48%-2122.96%33.91%113.11%
Return on Assets (ROA)
-94.99%-94.99%-64.85%-54.72%-31.76%-75.67%
Return on Invested Capital (ROIC)
1144.74%1144.74%-24955.70%-896.79%-776.80%17514.60%
Return on Capital Employed (ROCE)
-108.22%-108.22%-69.50%-57.71%-33.61%-79.83%
Earnings Yield
-55.66%-81.01%-14.43%-21.29%--
FCF Yield
-48.50%-66.18%-10.67%-6.03%--
Buyback Yield / Dilution
-2.52%-2.52%-145.12%-138.99%-24.25%-68.45%
Total Shareholder Return
-2.52%-2.52%-145.12%-138.99%-24.25%-68.45%
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q